165 related articles for article (PubMed ID: 25911330)
21. The clinical value of lung imaging fluorescence endoscopy for detecting synchronous lung cancer.
van Rens MT; Schramel FM; Elbers JR; Lammers JW
Lung Cancer; 2001 Apr; 32(1):13-8. PubMed ID: 11282424
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis of synchronous primary lung adenocarcinomas based on epidermal growth factor (EGFR) gene status: A case report.
Takuwa T; Tanaka F; Yoneda K; Torii I; Hashimoto M; Okumura Y; Matsumoto S; Kondo N; Hasegawa S
Lung Cancer; 2010 Jun; 68(3):498-500. PubMed ID: 20307913
[TBL] [Abstract][Full Text] [Related]
23. Genomic medicine in non-small cell lung cancer: paving the path to personalized care.
Sriram KB; Larsen JE; Yang IA; Bowman RV; Fong KM
Respirology; 2011 Feb; 16(2):257-63. PubMed ID: 21044232
[TBL] [Abstract][Full Text] [Related]
24. Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis.
Castañón E; Rolfo C; Viñal D; López I; Fusco JP; Santisteban M; Martin P; Zubiri L; Echeveste JI; Gil-Bazo I
J Transl Med; 2015 Aug; 13():257. PubMed ID: 26248464
[TBL] [Abstract][Full Text] [Related]
25. Synchronous primary lung adenocarcinomas harboring distinct MET Exon 14 splice site mutations.
Wang SXY; Lei L; Guo HH; Shrager J; Kunder CA; Neal JW
Lung Cancer; 2018 Aug; 122():187-191. PubMed ID: 30032829
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
27. Pathologic Assessment and Staging of Multiple Non-Small Cell Lung Carcinomas: A Paradigm Shift with the Emerging Role of Molecular Methods.
Chang JC; Rekhtman N
Mod Pathol; 2024 May; 37(5):100453. PubMed ID: 38387831
[TBL] [Abstract][Full Text] [Related]
28. Lung cancer. Special treatment issues.
Detterbeck FC; Jones DR; Kernstine KH; Naunheim KS;
Chest; 2003 Jan; 123(1 Suppl):244S-258S. PubMed ID: 12527583
[TBL] [Abstract][Full Text] [Related]
29. Synchronous lesions detected by autofluorescence bronchoscopy in patients with high-grade preinvasive lesions and occult invasive squamous cell carcinoma of the proximal airways.
Piérard P; Faber J; Hutsebaut J; Martin B; Plat G; Sculier JP; Ninane V
Lung Cancer; 2004 Dec; 46(3):341-7. PubMed ID: 15541819
[TBL] [Abstract][Full Text] [Related]
30. Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: implications for chemotherapy selection.
Broët P; Camilleri-Broët S; Zhang S; Alifano M; Bangarusamy D; Battistella M; Wu Y; Tuefferd M; Régnard JF; Lim E; Tan P; Miller LD
Cancer Res; 2009 Feb; 69(3):1055-62. PubMed ID: 19176396
[TBL] [Abstract][Full Text] [Related]
31. Surgical treatment of primary lung cancer with synchronous brain metastases.
Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
[TBL] [Abstract][Full Text] [Related]
32. Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules.
Zell JA; Ou SH; Ziogas A; Anton-Culver H
Cancer; 2008 Jan; 112(1):136-43. PubMed ID: 17960795
[TBL] [Abstract][Full Text] [Related]
33. The significance of intrapulmonary metastasis in non-small cell lung cancer: upstaging or downstaging? A re-appraisal for the next TNM staging system.
Oliaro A; Filosso PL; Cavallo A; Giobbe R; Mossetti C; Lyberis P; Cristofori RC; Ruffini E
Eur J Cardiothorac Surg; 2008 Aug; 34(2):438-43; discussion 443. PubMed ID: 18502660
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and management of synchronous lung cancers.
Ferguson MK; DeMeester TR; DesLauriers J; Little AG; Piraux M; Golomb H
J Thorac Cardiovasc Surg; 1985 Mar; 89(3):378-85. PubMed ID: 3974273
[TBL] [Abstract][Full Text] [Related]
35. Using Genomics to Differentiate Multiple Primaries From Metastatic Lung Cancer.
Murphy SJ; Harris FR; Kosari F; Barreto Siqueira Parrilha Terra S; Nasir A; Johnson SH; Serla V; Smadbeck JB; Halling GC; Karagouga G; Sukov WR; Leventakos K; Yang P; Peikert T; Mansfield AS; Wigle DA; Yi ES; Kipp BR; Vasmatzis G; Aubry MC
J Thorac Oncol; 2019 Sep; 14(9):1567-1582. PubMed ID: 31103780
[TBL] [Abstract][Full Text] [Related]
36. Staging of non-small cell lung cancer.
Tanoue LT
Semin Respir Crit Care Med; 2008 Jun; 29(3):248-60. PubMed ID: 18506663
[TBL] [Abstract][Full Text] [Related]
37. Prognostic modeling in early stage lung cancer: an evolving process from histopathology to genomics.
Harpole DH
Thorac Surg Clin; 2007 May; 17(2):167-73, viii. PubMed ID: 17626395
[TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor receptor tyrosine kinase inhibitors in early-stage nonsmall cell lung cancer.
Spaans JN; Goss GD
Curr Opin Oncol; 2015 Mar; 27(2):102-7. PubMed ID: 25611026
[TBL] [Abstract][Full Text] [Related]
39. [Curative surgical treatment options for patients with non-small cell lung cancer (NSCLC) and solitary pulmonary metastasis].
Tönnies M; Kollmeier J; Bauer TT; Griff S; Kaiser D
Pneumologie; 2012 Apr; 66(4):218-23. PubMed ID: 22477482
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancer.
He YY; Zhang XC; Yang JJ; Niu FY; Zeng Z; Yan HH; Xu CR; Guan JL; Zhong WZ; Yang LL; Guo LH; Wu YL
Clin Lung Cancer; 2014 Nov; 15(6):441-7. PubMed ID: 25044104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
